Diagnosis of coronary artery rethrombosis after effective systemic thrombolytic therapy in patients with ST-segment

Valentin E Oleynikov1, Simon Matskeplishvili2, Ekaterina Shigotarova3

  • 1Therapy Department, Penza State University, Penza, Russian Federation v.oleynikof@gmail.com.

Insights

ST-segment re-elevation in patients with ST-segment elevation myocardial infarction (STEMI) treated with thrombolytic therapy (TLT) indicates coronary artery reocclusion. Continuous ECG monitoring is crucial for detecting silent ischemia and guiding interventions.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Interventional Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring prompt treatment.
  • Thrombolytic therapy (TLT) is a common reperfusion strategy for STEMI.
  • Recurrent coronary artery thrombosis can occur despite successful initial treatment.

Purpose of the Study:

  • To assess the diagnostic value of ST-segment re-elevation episodes detected by telemetric ECG monitoring.
  • To correlate these ECG findings with angiographically confirmed coronary artery reocclusion in STEMI patients treated with TLT.
  • To evaluate the incidence of asymptomatic myocardial ischemia in this patient cohort.

Main Methods:

  • Study included 117 patients with STEMI after effective TLT.
  • Telemetric ECG monitoring was performed using the AstroCard Telemetry system.
  • Coronary angiography was conducted 3-24 hours post-TLT to assess infarct-related artery status.

Main Results:

  • ST-segment re-elevation episodes were observed in 32 patients (27.4%).
  • Coronary artery thrombosis was confirmed in 84.4% of patients with ST-segment re-elevation (Group 2) versus 9.4% without (Group 1) (p<0.01).
  • Recurrent ischemic episodes were asymptomatic in 71.9% of cases in Group 2 (p<0.01).

Conclusions:

  • ST-segment re-elevation during remote ECG monitoring is a strong indicator of coronary artery thrombotic reocclusion in STEMI patients post-TLT.
  • Continuous ECG telemetry is essential for identifying patients with silent myocardial ischemia and potential reocclusion.
  • Early detection facilitates timely selection for rescue percutaneous coronary interventions.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
46
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
74
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
58
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
103